Table F.5.
Panel of antimicrobial substances included in AMR monitoring, EUCAST ECOFFs and concentration ranges tested in Salmonella spp. and indicator commensal E. coli (first panel) as laid down in Commission Implementing Decision 2013/652/EU
| Antimicrobial |
Salmonella EUCAST ECOFF( a ) |
E. coli EUCAST ECOFF( a ) |
Concentration range, mg/L (no. of wells) |
|---|---|---|---|
| Ampicillin | > 8 | > 8 | 1–64 (7) |
| Cefotaxime | > 0.5 | > 0.25 | 0.25–4 (5) |
| Ceftazidime | > 2 | > 0.5 | 0.5–8 (5) |
| Meropenem | > 0.125 | > 0.125 | 0.03–16 (10) |
| Nalidixic acid | > 16 | > 16 | 4–128 (6) |
| Ciprofloxacin | > 0.064 | > 0.064 | 0.015–8 (10) |
| Tetracycline | > 8 | > 8 | 2–64 (6) |
| Colistin | > 2 | > 2 | 1–16 (5) |
| Gentamicin | > 2 | > 2 | 0.5–32 (7) |
| Trimethoprim | > 2 | > 2 | 0.25–32 (8) |
| Sulfamethoxazole | NA( b ) | > 64 | 8–1,024 (8) |
| Chloramphenicol | > 16 | > 16 | 8–128 (5) |
| Azithromycin | NA( c ) | NA( c ) | 2–64 (6) |
| Tigecycline | > 1 | > 1 | 0.25–8 (6) |
AMR: antimicrobial resistance; ECOFFs: epidemiological cut‐off values; EUCAST: European Committee on Antimicrobial Susceptibility Testing; NA: not available.
(a)
EUCAST epidemiological cut‐off values available in Decision 2013/652/EU was drafted (2013). ‘>’ than the ECOFF, criteria used for determing microbiological resistance.
(b)
> 256 mg/L was used.
(c)
> 16 mg/L was used.